Sigachi Industries Limited — Updates, 28-04-2025: Press Release

Sigachi MENA FZCO, a wholly owned subsidiary of Sigachi Industries Limited, has signed a Memorandum of Understanding (MoU) with Respilon Group s.r.o. This partnership will leverage Respilon’s NUENEX® nanofiber technology to enhance non-invasive drug delivery systems, aiming for improved patient outcomes. The collaboration focuses on developing Invisible Patch and Powder-based delivery formats, along with commercialization strategies for active pharmaceutical ingredients (APIs) through nanofiber encapsulation.

Commenting on the collaboration, Sigachi’s Managing Director and CEO, Amit Raj Sinha, highlighted a shared vision to innovate pharmaceutical solutions globally. Respilon’s Chief Business Officer, Roman Zima, expressed enthusiasm for Sigachi's expertise, which is expected to accelerate the adoption of NUENEX® in pharmaceutical markets. This strategic alliance signifies a noteworthy step in Sigachi's expansion into advanced drug delivery technologies, enhancing its market positioning and potential growth in the pharmaceutical industry.